Open AccessUltrastructure of IL2‐stimulated Tumor‐infiltrating Lymphocytes Showing Cytolytic Activity Against Tumor Cells
Author(s) -
Tanaka Hisako,
Watanabe Michiko,
Zeniya Mikio,
Takahashi Hiroki
Publication year - 1991
Publication title -
acta patholigica japonica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.73
H-Index - 74
ISSN - 0001-6632
DOI - 10.1111/j.1440-1827.1991.tb02504.x
Subject(s) - cytotoxic t cell , tumor infiltrating lymphocytes , lymphokine activated killer cell , cytolysis , biology , ultrastructure , pathology , interleukin 2 , effector , lewis lung carcinoma , cd8 , chemistry , cancer research , microbiology and biotechnology , immunology , interleukin 12 , cytokine , in vitro , antigen , medicine , cancer , biochemistry , genetics , metastasis
Tumor‐infiltrating lymphocytes (TIL) obtained from tumor tissue and pleural effusion of breast carcinoma were cultured with interleukin‐2 (IL2) and thus activated. The ultrastructure of TIL stimulated by IL2 to kill various breast carcinoma cells was then investigated. Freshly isolated TIL cultured with autologous tumor cells for 48 h without IL2 were small, round and showed neither binding to nor killing of tumor cells. TIL stimulated to proliferate by IL2 became effector cells and showed cytotoxicity against tumor cells. Ultrastructurally, the effector TIL resembled large granular lymphocytes, and adhered to tumor cells through interdigitation or close apposition of the two plasma membranes accompanied by spot‐like close membrane contacts. At the site of each spot‐like contact, there was a 5‐nm intercellular space. The morphology of the TIL processes did not differ from those of LAK and other CTL or NK cell processes during contact, invagination or the killing of target cells. The granules in TIL were considered to participate in the cytotoxic effect. Phenotypically heterogeneous TIL, CD87CD57‐ and CD8 + /CD57 + , adhered to autologous tumor cells and MCF7 (human breast carcinoma cell line). However, it was unclear which cell or cells acted as the effector for tumor‐cell killing. Acta Pathol Jpn 41: 94‐105, 1991.